Contents of this document
- Sales and expansion of mushroom-based meat
- Research and product development related to the health functionality of maitake mushrooms
- Participation in a regional industrial cluster plan
- Operational Efficiency Through BPR
- Labor saving and energy conservation through new investment
- Core operating profit¥727 millionYear-on-year (%)572.5
- Core EBITDA¥1,928 millionYear-on-year (%)56.9
- Core EBITDA margin11.7 %Year-on-year change (points)3.5
- Basic earnings per share¥25.63
- ROE28.8 %Year-on-year change (points)21.7
- ROIC12.2 %Year-on-year change (points)4.1
- Net debt-to-equity ratio1 x
- Net debt-to-core EBITDA2.1 x
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | ¥16,482 million (YoY +10.2%) |
| Operating profit | ¥1,749 million (YoY +305.2%) |
| Net income | ¥1,022 million (YoY +1,152.2%) |
| Operating profit margin | 10.6 |
| Selling, general and administrative expenses | ¥4,552 million |
| Results for the three months of the current quarter | Revenue ¥8,499 million / Core EBITDA ¥1,097 million |
| Full-year earnings forecast | Revenue ¥39,640 million / Operating profit ¥4,140 million / Pretax profit ¥3,950 million / Profit for the year attributable to owners of the parent ¥2,540 million / Core operating profit ¥3,960 million / Core EBITDA ¥6,450 million |
| Segment results | Mushroom business Revenue ¥16,274 million / yoy_pct 10 / Maitake mushrooms Revenue ¥8,490 million / yoy_pct 12.3 / King oyster mushrooms Revenue ¥1,906 million / yoy_pct 7.1 / Bunashimeji mushrooms Revenue ¥3,445 million / yoy_pct 6.2 / Other mushrooms Revenue ¥2,431 million / yoy_pct 9.9 / Other Businesses Revenue ¥208 million / yoy_pct 30.3 |
| Breakdown of Factors Affecting the Change | Core EBITDA YoY Revenue 1,523 / Costs of sales -672 / Selling, general and administrative expenses -151 |
| Key KPIs | Indicator name Core operating profit / Value ¥727 million / Year-on-year (%) ¥572.5 million, Indicator name Core EBITDA / Value ¥1,928 million / Year-on-year (%) ¥56.9 million, Indicator name Core EBITDA margin / Value 11.7 % / Year-on-year change (points) 3.5 %, Indicator name Basic earnings per share / Value ¥25.63 / Year on year against the same period last year Not disclosed, Indicator name ROE / Value 28.8 % / Year-on-year change (points) 21.7 %, Indicator name ROIC / Value 12.2 % / Year-on-year change (points) 4.1 %, Indicator name Net debt-to-equity ratio / Value 1 x / Year on year against the same period last year Not disclosed, Indicator name Net debt-to-core EBITDA / Value 2.1 x / Year on year against the same period last year Not disclosed |
| Unit price and quantity metrics | Maitake mushrooms Sales volume vs. prior-year period (%) 110.2 / Sales volume vs. plan (%) 101.8 / Selling price per unit vs. prior-year period (%) 101.9 / Selling price per unit vs. plan (%) 104.1 / King oyster mushrooms Sales volume vs. prior-year period (%) 103.8 / Sales volume vs. plan (%) 95.1 / Selling price per unit vs. prior-year period (%) 103.1 / Selling price per unit vs. plan (%) 98 / Bunashimeji mushrooms Sales volume vs. prior-year period (%) 99.5 / Sales volume vs. plan (%) 97.1 / Selling price per unit vs. prior-year period (%) 107.5 / Selling price per unit vs. plan (%) 105.6 / 3 other mushroom products Sales volume vs. prior-year period (%) 122.9 / Sales volume vs. plan (%) 99.1 / Selling price per unit vs. prior-year period (%) 94.2 / Selling price per unit vs. plan (%) 88.5 |
| Number of employees | Number of Employees Not disclosed / Changes during the period and hiring plan Labor saving of more than 200 people |
| Assumptions Underlying the Business Outlook | Market Supply Volume Expected to remain stable / Vegetable prices At risk of fluctuating due to weather and other factors / Consumer Trends A trend toward selective spending / Geopolitical Risk Expected to persist / Labor costs The upward trend is expected to continue |
| Medium-term management plan targets | Fiscal year ending March 2028 Revenue More than ¥42 billion / Overseas revenue ratio Around 6–7% / Core EBITDA margin Approximately 18% / ROIC Approximately 10% |
| Financial targets | ROIC Target for the fiscal year ending March 2028 Approximately 10% / Second-quarter actuals for the fiscal year ending March 2027 12.2% / ROE Second-quarter actuals for the fiscal year ending March 2027 28.8% |
| Capital expenditures | ¥1,632 million |
| Market Size / Share | Maitake mushrooms Domestic market share 51 % / King oyster mushrooms Domestic market share 25 % / Bunashimeji mushrooms Domestic market share 13 % / Hon-shimeji mushrooms Domestic market share 99 % / Hatake-shimeji mushrooms Domestic market share 94 % / Mushrooms Domestic market share 33 % |
| New initiatives | Sales and expansion of mushroom-based meat, Research and product development related to the health functionality of maitake mushrooms, Participation in a regional industrial cluster plan, Operational Efficiency Through BPR, Labor saving and energy conservation through new investment |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Higher sales volume, sustained high unit prices, an optimized product mix, the acquisition of new customers and expanded sales channels contributed to higher revenue. Although material, utility and freight unit costs increased, the impact was contained by limiting cost increases, improving load efficiency and achieving efficiencies through BPR.